Single-Center Study Evaluating the Impact of Age on the Diagnostic Performance of the Sural-to-Radial Sensory Amplitude Ratio in Length-Dependent and Non-Length-Dependent Peripheral Polyneuropathies
NCT07725120 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2026-07-24
Summary
This retrospective single-center observational study will evaluate the impact of age on the diagnostic performance of the sural-to-radial sensory nerve amplitude ratio (SRAR) in patients with length-dependent and non-length-dependent peripheral sensory polyneuropathies. Clinical and electrophysiological data collected during routine care between January 2013 and July 2026 will be analyzed. Diagnostic performance will be assessed using receiver operating characteristic (ROC) curve analysis across predefined age groups to determine whether age-adjusted SRAR thresholds improve the differentiation between the two polyneuropathy phenotypes.
Conditions
- Polyneuropathies
- Electromyography
- Diagnostic Techniques
Interventions
- OTHER
-
Retrospective Medical Record Review
This observational study involves retrospective collection and analysis of routinely acquired clinical and electrophysiological data from approximately 180 patients with sensory polyneuropathy. Data extracted from medical records include demographic characteristics, clinical diagnosis, and nerve conduction study parameters, including sural and radial sensory nerve action potential amplitudes used to calculate the sural/radial amplitude ratio (SRAR). No additional diagnostic procedures, treatments, or study-specific assessments are performed. All data are obtained from standard clinical care.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nice
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2026-12-31
Countries
- France
Study Locations
More Related Trials
-
A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy
NCT07610564 ·Status: RECRUITING ·Phase: PHASE1
-
Causes Associated With Small Fiber Neuropathy (SFN).
NCT04170205 ·Status: UNKNOWN
-
Normative Data of Intra-epidermal Nerve Fiber Density
NCT01498211 ·Status: COMPLETED ·Phase: NA
-
Ultrasonography in Diagnosis of Polyneuropathy
NCT06390527 ·Status: NOT_YET_RECRUITING
-
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
NCT05546138 ·Status: RECRUITING
-
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
NCT04699734 ·Status: RECRUITING ·Phase: NA
-
The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
NCT00228345 ·Status: TERMINATED ·Phase: PHASE1
-
Genetic, Environment and Its Interaction Analysis for Cardiovascular Autonomic Neuropathy
NCT02461342 ·Status: COMPLETED
-
Probing the Role of Sodium Channels in Painful Neuropathies
NCT02243475 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
NCT04431778 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic Value of Biomarkers in Polyneuropathy.
NCT06044662 ·Status: RECRUITING
-
Diagnostic Accuracy of Quantitative Neuropad Test for Diabetic Peripheral Neuropathy
NCT05347420 ·Status: UNKNOWN
-
Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management
NCT05620225 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy
NCT05219383 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT03219320 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT06203002 ·Status: COMPLETED ·Phase: PHASE2
-
An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients
NCT02429947 ·Status: COMPLETED
-
The Effects of Passive Vibration in Patients With Diabetic Peripheral Neuropathy
NCT03415256 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED
-
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
NCT06074562 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT00322621 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
NCT01625182 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury
NCT01112748 ·Status: COMPLETED ·Phase: PHASE4
-
NT-3 Levels and Function in Individuals With CMT
NCT05011006 ·Status: TERMINATED